Sanofi-Aventis U.S. LLC et al v. IMPAX Laboratories, Inc. > Summary
Court Case Number 1:17-cv-00004
Filing Date Jan 3, 2017
Termination Date Apr 21, 2017
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesGregory M. Sleet
Defendant
Plaintiff Attorneys
14Sanofi
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Aventisub LLC
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Brandon J. Kennedy
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Ann C. Palma
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Ann C. Palma
McDonnell Boehnen Hulbert & Berghoff LLP
Aventisub LLC
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Defendant Attorneys
2Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Nov 17, 2015 |
| 06794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 21, 2004 |
